- Display 15 Products per page
Published: September 13, 2018 | Price: $2,500.00 – $5,000.00
The IVD Market in South Korea The IVD Market in South Korea provides an overview of the in vitro diagnostics market in South Korea and its influences. The focus is on the following IVD market sub-segments: clinical chemistry, immunoassays, microbiology and molecular testing, point-of-care testing, and histology/cytology. The market data provided give an overview of developments in the in vitro diagnostics industry in South Korea, presenting IVD revenues by extracted market segment for 2017 and 2022, which includes general chemistry,...Published: February 26, 2024 | Price: $5,000.00 – $10,500.00
The IVD Market in South Korea, 2024 offers a comprehensive overview of the in vitro diagnostics (IVD) market in South Korea and the factors shaping it. The report presents South Korea's IVD revenues for 2023 and forecasts for 2028, segmented into clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology/cytology. Included in the report are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences. The report...Published: July 5, 2018 | Price: $3,995.00 – $7,990.00
The search for emerging markets is necessary part of growth strategy in IVD. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East. The countries covered are: Egypt Iran Iraq Israel Jordan Saudi Arabia Turkey United Arab Emirates (UAE) Other Mideast The Middle East market for in vitro diagnostics is provided in U.S....Published: September 14, 2018 | Price: $2,500.00 – $5,000.00
The IVD Market in VietnamThe IVD Market in Vietnam provides an overview of the in vitro diagnostics market in Vietnam and its influences. The focus is on the following IVD market sub-segments: clinical chemistry, immunoassays, microbiology and molecular testing, point-of-care testing, and histology/cytology. The market data provided give an overview of developments in the in vitro diagnostics industry in Vietnam, presenting IVD revenues by extracted market segment for 2017 and 2022, which includes general chemistry, blood gas analysis, urinalysis, infectious...Published: August 19, 2015 | Price: $1,995.00 – $3,990.00
The IVD Market in Vietnam presents current analysis of the Vietnamese IVD industry. Vietnam has demonstrated fast economic growth in recent years. Increases in foreign investment, wages, trade, industrialization and tourism have led to economic growth higher than that of many other economies in Asia. As a result, IVD companies searching for emerging market areas to pursue growth that is no longer possible in developed nations have targeted Vietnam. The report takes an in-depth look at the market, providing data...Published: March 11, 2020 | Price: $4,000.00 – $8,000.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche compete in this segment, influenza competitors Sekisui and Quidel also operate, as do specialty concerns such as Curetis, Biocartis, and a host of small but innovative players. Molecular point of care or...Published: February 7, 2023 | Price: $5,000.00 – $10,000.00
This report is an essential tool for understanding the size and growth opportunity in molecular POC. Molecular point of care (mPOC) has gone from novel trend to significant contributor to the market. The instruments sold by Abbott, BioMérieux, Cepheid and increasingly, a host of other companies, are a significant contributor to the IVD POC market. Knowing these markets is essential to knowing the opportunity in point of care testing and microbiology IVD. Since 2013, Kalorama has been producing a dedicated...Published: March 24, 2022 | Price: $5,000.00 – $10,000.00
The Market and Future Potential for Molecular Point of Care (POC), 2022 provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular point of care or mPOC systems are designed to be faster than lab-based tests while...Published: March 7, 2024 | Price: $5,000.00 – $10,500.00
Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests. They expand diagnostic capabilities in critical care units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology. Kalorama Information has been covering mPOC on a regular basis since 2013. Our latest report, The Market and Future Potential for Molecular Point-of-Care (mPOC),...Published: January 22, 2021 | Price: $4,000.00 – $8,000.00
This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular point of care or mPOC systems are designed to be faster than lab-based tests while more accurate than existing point of care systems. Development of...Published: January 25, 2018 | Price: $3,995.00 – $7,900.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ Among the various technologies and products of the global in vitro diagnostics (IVD) market, molecular diagnostics performed at the point of care or near the patient are regarded as a leading expansion market. Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics,...Published: February 22, 2019 | Price: $4,000.00 – $8,000.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ Molecular diagnostics performed at the point of care or near the patient is regarded as a leading expansion segment in the global in vitro diagnostics (IVD) market. Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the...Published: February 5, 2014 | Price: $2,995.00 – $5,990.00
The Market and Potential for Molecular Point of Care Diagnostics Molecular Point of Care is a budding field in medical diagnostics. Kalorama's report, The Market and Potential for Molecular Point of Care Diagnostics, provides the most current look at this field. To assess the opportunity, Kalorama's report examines the molecular diagnostics business and also the point-of-care (POC) diagnostics business as they are now, and then examines at the new combination products. A good number of companies are producing or...Published: February 26, 2016 | Price: $3,360.00 – $6,720.00
Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the developing world.bThe Market and Potential for Molecular Point of Care Diagnostics examines the major segments of molecular POC diagnostics, exploring in-depth current sales and market opportunity and providing the following market information: Molecular POC Market for...Published: April 17, 2015 | Price: $499.00 – $1,000.00
The Market for Clinical Chemistry Routine clinical chemistry comprises 30 to 40 tests of substrates, metabolites, electrolytes, blood gases, enzymes and lipids that can be organized into panels for specialty patient investigation and routine patient screening. Common specialty panels include those for renal clearance, liver function, and metabolic status. Clinical chemistries are performed on analyzers with varying levels of automation depending on the test volume run at a particular test site. The market for routine clinical chemistries can be segmented...